AbbVie Newsroom

Piper Sandler has raised AbbVie's Target Price to $220.

Gelonghui FinanceDec 18 14:28

AbbVie Analyst Ratings

BenzingaDec 18 01:33

Piper Sandler Maintains AbbVie(ABBV.US) With Buy Rating, Raises Target Price to $220

Futu NewsDec 17 20:33

Analysts Offer Insights on Healthcare Companies: AbbVie (ABBV), Alcon (ALC) and Humana (HUM)

TipRanksDec 17 20:13

BofA Securities Maintains AbbVie(ABBV.US) With Hold Rating, Announces Target Price $191

Futu NewsDec 11 16:32

AbbVie Analyst Ratings

BenzingaDec 10 20:38

B of A Securities Reinstates Neutral on AbbVie, Announces $191 Price Target

BenzingaDec 10 20:38

Citi Maintains AbbVie(ABBV.US) With Buy Rating

Futu NewsDec 10 20:31

Analysts Are Bullish on Top Healthcare Stocks: AbbVie (ABBV), Protagonist Therapeutics (PTGX)

TipRanksDec 10 19:47

TD Cowen Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $225

Futu NewsDec 10 19:35

AbbVie: Strong Buy Rating Based on Growth Potential and Strategic Positioning

TipRanksDec 10 18:50

Positive Outlook for Aldeyra Therapeutics: Buy Rating Backed by Promising Reproxalap Prospects and Strategic Partnership With AbbVie

TipRanksDec 9 19:34

AbbVie: Resilient Market Position and Growth Potential Justify Buy Rating

TipRanksDec 6 00:06

Daiwa Securities Downgrades AbbVie to Neutral From Outperform, Adjusts Price Target to $180 From $210

MT NewswiresDec 5 18:36

Alector Downgraded to Underperform at BofA After Alzheimer's Trial Miss

Seeking AlphaDec 5 01:26

AbbVie Analyst Ratings

BenzingaNov 22 20:45

Leerink Partners Upgrades AbbVie(ABBV.US) to Buy Rating, Announces Target Price $206

Futu NewsNov 22 19:31

Wells Fargo Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $195

Futu NewsNov 19 16:38

Wells Fargo Adjusts Price Target on AbbVie to $195 From $205, Maintains Overweight Rating

MT NewswiresNov 18 23:46

Redburn Atlantic Adjusts AbbVie's Price Target to $216 From $215, Keeps Buy Rating

MT NewswiresNov 16 01:44